Pharmaceuticals 2010, 3(2), 433-440; doi:10.3390/ph3020433
Review

The Vasohibin Family

Department of Vascular Biology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan
Received: 13 January 2010; in revised form: 23 January 2010 / Accepted: 3 February 2010 / Published: 5 February 2010
(This article belongs to the Special Issue Angiogenesis Inhibitors)
PDF Full-text Download PDF Full-Text [103 KB, uploaded 5 February 2010 09:57 CET]
Abstract: Angiogenesis is regulated by the local balance between angiogenesis stimulators and inhibitors. A number of endogenous angiogenesis inhibitors have been found in the body. The origin of these inhibitors is mostly extrinsic to the vasculature. Recently, however, vascular endothelial cells themselves have been found to produce angiogenesis inhibitors including vasohibin-1. These intrinsic inhibitors are thought to regulate angiogenesis by an auto-regulatory or negative-feedback mechanism. This review will focus on vasohibin-1 produced by vascular endothelial cells and on its homologue, vasohibin-2.
Keywords: endothelial cell; negative feedback; mononuclear cell; bone marrow

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Sato, Y. The Vasohibin Family. Pharmaceuticals 2010, 3, 433-440.

AMA Style

Sato Y. The Vasohibin Family. Pharmaceuticals. 2010; 3(2):433-440.

Chicago/Turabian Style

Sato, Yasufumi. 2010. "The Vasohibin Family." Pharmaceuticals 3, no. 2: 433-440.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert